Lumos Diagnostics
Lumos Diagnostics specializes in developing, manufacturing, and distributing rapid point-of-care diagnostic technologies, including products like FebriDx and ViraDx, and is listed on the Australian Securities Exchange under the ticker ASX:LDX.
About Lumos Diagnostics
Lumos Diagnostics develops, manufactures, and distributes point-of-care diagnostic technologies. The company is listed on the Australian Securities Exchange under the ticker symbol ASX:LDX. Specializing in rapid, cost-effective diagnostic test solutions, Lumos Diagnostics provides healthcare professionals with tools to improve patient care through innovative testing methods.
Services
Lumos Diagnostics offers a range of services including customized assay development, manufacturing, and support for diagnostic products. Their services cover strategic innovation, development, and manufacturing transfer for point-of-care diagnostic test products. The company also provides clinical and product validation as well as commercial-scale manufacturing of test strips and readers. Their in-house team is qualified in medical, quality, and regulatory affairs, ensuring that all products meet stringent healthcare standards.
Products
Lumos Diagnostics offers various point-of-care diagnostic products designed for rapid and precise testing. Key products include FebriDx and ViraDx. FebriDx uses a fingerstick blood sample to help differentiate between bacterial and non-bacterial infections. ViraDx is a multi-pathogen test that simultaneously screens for COVID-19, Influenza A, and Influenza B. These products are aimed at improving clinical decision-making and patient outcomes through quick and reliable diagnostics.
Custom Assay Development
Lumos Diagnostics specializes in custom assay development and manufacturing services for point-of-care tests and proprietary digital reader platforms. The company provides tailored solutions to meet the specific needs of healthcare providers, ensuring that diagnostic tests are efficient and reliable. Their suite of custom services supports the development of innovative diagnostic test products in key global markets.